1. Home
  2. HOTH vs PCLA Comparison

HOTH vs PCLA Comparison

Compare HOTH & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hoth Therapeutics Inc.

HOTH

Hoth Therapeutics Inc.

N/A

Current Price

$1.07

Market Cap

17.7M

Sector

Health Care

ML Signal

N/A

Logo PicoCELA Inc. American Depositary Shares

PCLA

PicoCELA Inc. American Depositary Shares

N/A

Current Price

$2.31

Market Cap

18.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
HOTH
PCLA
Founded
2017
2008
Country
United States
Japan
Employees
3
55
Industry
Biotechnology: Pharmaceutical Preparations
Building Products
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
18.2M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
HOTH
PCLA
Price
$1.07
$2.31
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
353.2K
10.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$0.12
52 Week High
$2.12
$8.00

Technical Indicators

Market Signals
Indicator
HOTH
PCLA
Relative Strength Index (RSI) 55.60 30.00
Support Level $0.99 $0.35
Resistance Level $1.12 $3.74
Average True Range (ATR) 0.06 0.48
MACD 0.01 -0.31
Stochastic Oscillator 36.65 1.34

Price Performance

Historical Comparison
HOTH
PCLA

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: